Uncategorized
NovaBay Pharmaceuticals Reports 2021 Fourth Quarter and Full Year Financial Results
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three and 12 months ended December 31, 2021 and provides a business update. Financial results include the operations of the acquired DERMAdoctor business beginning November 5, 2021. “NovaBay closed out an eventful year on a high note with fourth quarter net product revenue increasing 40% over the prior-year period on record Avenova spray unit sales,” said Justin Hall, NovaB